Principles of clinical immunosuppression.
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007239:Infections / Q000209:etiology; D007674:Kidney Diseases / Q000532:radiotherapy; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D009369:Neoplasms / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011878:Radiotherapy; D013256:Steroids / Q000627:therapeutic use; D013897:Thoracic Duct / Q000601:surgery
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D013256:Steroids; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone